Overall Survival and Role of Programmed Death Ligand 1 Expression in Patients With Metastatic Non-Small-Cell Lung Cancer and Immunotherapy: An Observational Study from Central Switzerland. Swiss Med Wkly 2023, 153 (1), 40039. https://doi.org/10.57187/smw.2023.40039.